[PAGID] Disseminated mycobacterium

Kathleen E. Sullivan sullivak at mail.med.upenn.edu
Fri Apr 25 12:53:07 EDT 2008


Don't forget CGD.
Kathleen E. Sullivan MD PhD
Chief, Division of Allergy and Immunology
Professor of Pediatrics
The Children's Hospital of Philadelphia
(p) 215-590-1697
(f) 267-426-0363


On Apr 25, 2008, at 12:45 PM, Chris Seroogy wrote:


> Dear Colleagues:

>

> I would like your advice on management of a 19 m/o previously healthy

> caucasion girl who presented 4 days ago with thrombocyopenia and

> anemia.

> Her bone marrow biopsy revealed numerous AFB+ organisms. Her blood

> grew

> mycobacterium and pneumococcus and her stool is growing mycobacterium.

> Further identification is pending. She has tremendous

> hepatospenomegaly and

> high fevers. Family history is incomplete as mother is adopted and

> parents

> are unlikely related. She is fully immunized (including live

> vaccines). ALC

> 2020, IgG and IgM elevated for age. She is being treated with a

> "cocktail"

> of antimicrobials for mycobacterium per our ID team and

> vancomycin. She

> remains critically ill.

>

> It seems likely that she has a defect in IFN-g/IL-12 axis. We will be

> sending blood to Steve Holland next week. In the interim, I would

> like

> opinions about using IFN-g (or perhaps IFN-a if this is a complete

> IFNR1

> defect.) Have any of you empirically used IFN-g in this setting?

> Is there

> any downside? How rapid should improvement be observed if there is a

> functioning IFNR? Thank you for your insights, Chris

>

>

> Chris Seroogy, M.D.

>

> University of Wisconsin

>

> Assistant Professor

>

> Dept. of Pediatrics

>

> Mail: H4/474 CSC, Mailstop 4108

>

> Shipping: H4/431 CSC, Mailstop 4108

>

> 600 Highland Ave.

>

> Madison, WI 53792

>

> phone: 608- 263-2652

>

> fax: 608-265-0164

>

>

>


-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://seven.pairlist.net/mailman/private/pagid/attachments/20080425/4b84a555/attachment.html>


More information about the PAGID mailing list